These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

12447 related articles for article (PubMed ID: 1106841)

  • 1. Clinical phase I trial of inosine dialdehyde (NSC-118994).
    Kaufman J; Mittelman A
    Cancer Chemother Rep; 1975; 59(5):1007-14. PubMed ID: 1106841
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical trials with diglycoaldehyde (NSC-118994): review and reasons for withdrawal from clinical trial.
    Chiuten DF; Vosika GJ; Shaw MT; Boiron M; Gisselbrecht C; Marty M; Higgins G; Muggia FM
    Anticancer Res; 1981; 1(2):121-4. PubMed ID: 7347155
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Canine and human renal toxicity of inosine dialdehyde (NSC 118994).
    Kaufman J; Keogh B; Mittelman A; Wallens T; Murphy GP
    J Med; 1977; 8(3-4):239-51. PubMed ID: 267714
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phase II study of diglycoaldehyde in malignant melanomas and soft tissue sarcomas.
    Vosika GJ; Briscoe K; Carey RW; O'Donnell JF; Perry MC; Budman D; Richards F; Coleman M
    Cancer Treat Rep; 1981; 65(9-10):823-5. PubMed ID: 7273013
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phase I study of carboplatin (CBDCA) in children with cancer.
    Bacha DM; Caparros-Sison B; Allen JA; Walker R; Tan CT
    Cancer Treat Rep; 1986 Jul; 70(7):865-9. PubMed ID: 3521846
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phase II evaluation of diglycoaldehyde (Inox) in children with acute leukemia: a children's cancer study group report.
    Higgins GR; Finklestein J; Krivit W; Hammond D
    Cancer Treat Rep; 1980; 64(4-5):625-8. PubMed ID: 7427952
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phase I study of carboplatin given on a five-day intravenous schedule.
    Rozencweig M; Nicaise C; Beer M; Crespeigne N; Van Rijmenant M; Lenaz L; Kenis Y
    J Clin Oncol; 1983 Oct; 1(10):621-6. PubMed ID: 6366128
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phase I study of methanesulfonamide, N-[4-(9-acridinylamino)-3-methoxyphenyl]-(m-AMSA) using a single-dose schedule.
    Von Hoff DD; Howser K; Gormley P; Bender RA; Glaubiger D; Levine AS; Young RC
    Cancer Treat Rep; 1978 Oct; 62(10):1421-6. PubMed ID: 361222
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phase I trial of menogaril administered as an intermittent daily infusion for 5 days.
    Sigman LM; Van Echo DA; Egorin MJ; Whitacre MY; Aisner J
    Cancer Treat Rep; 1986 Jun; 70(6):721-5. PubMed ID: 2942244
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phase I clinical trial of mitozolomide.
    Newlands ES; Blackledge G; Slack JA; Goddard C; Brindley CJ; Holden L; Stevens MF
    Cancer Treat Rep; 1985; 69(7-8):801-5. PubMed ID: 4016790
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phase I clinical and pharmacokinetic trial of Brequinar sodium (DuP 785; NSC 368390).
    Arteaga CL; Brown TD; Kuhn JG; Shen HS; O'Rourke TJ; Beougher K; Brentzel HJ; Von Hoff DD; Weiss GR
    Cancer Res; 1989 Aug; 49(16):4648-53. PubMed ID: 2743343
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phase II clinical evaluation of doxifluridine.
    Hurteloup P; Armand JP; Cappelaere P; Metz R; Kerbrat P; Keiling R; Fumoleau P; Fargeot P; Schraub S; Bastit P
    Cancer Treat Rep; 1986 Jun; 70(6):731-7. PubMed ID: 2942245
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of advanced adult acute leukemia with diglycoaldehyde: a Southwest Oncology Group study.
    Shaw MT; Morrison FS; Stuckey WJ; Trowbridge AA
    Cancer Treat Rep; 1980; 64(8-9):985-8. PubMed ID: 7004636
    [No Abstract]   [Full Text] [Related]  

  • 14. Phase I and pharmacokinetic study of arabinofuranosyl-5-azacytosine (fazarabine, NSC 281272).
    Surbone A; Ford H; Kelley JA; Ben-Baruch N; Thomas RV; Fine R; Cowan KH
    Cancer Res; 1990 Feb; 50(4):1220-5. PubMed ID: 1688736
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phase I trial and pharmacokinetics of trimelamol (N2,N4,N6-trihydroxymethyl-N2,N4,N6-trimethylmelamine).
    Judson IR; Calvert AH; Rutty CJ; Abel G; Gumbrell LA; Graham MA; Evans BD; Wilman DE; Ashley SE; Cairnduff F
    Cancer Res; 1989 Oct; 49(19):5475-9. PubMed ID: 2670205
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phase I trial of chlorozotocin.
    Gralla RJ; Tan CT; Young CW
    Cancer Treat Rep; 1979 Jan; 63(1):17-20. PubMed ID: 154363
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oral topotecan given once or twice daily for ten days: a phase I pharmacology study in adult patients with solid tumors.
    Gerrits CJ; Burris H; Schellens JH; Eckardt JR; Planting AS; van der Burg ME; Rodriguez GI; Loos WJ; van Beurden V; Hudson I; Fields S; Von Hoff DD; Verweij J
    Clin Cancer Res; 1998 May; 4(5):1153-8. PubMed ID: 9607572
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Phase 2 trial of the liposomal DACH platinum L-NDDP in patients with therapy-refractory advanced colorectal cancer.
    Dragovich T; Mendelson D; Kurtin S; Richardson K; Von Hoff D; Hoos A
    Cancer Chemother Pharmacol; 2006 Dec; 58(6):759-64. PubMed ID: 16847673
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phase I trial of teroxirone.
    Neidhart JA; Derocher D; Grever MR; Kraut EH; Malspeis L
    Cancer Treat Rep; 1984 Sep; 68(9):1115-9. PubMed ID: 6478450
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A phase of I trial of 4'-epi-Adriamycin.
    Schauer PK; Wittes RE; Gralla RJ; Casper ES; Young CW
    Cancer Clin Trials; 1981; 4(4):433-7. PubMed ID: 7318126
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 623.